SRM Assay to Indicate Cancer Therapy
US-2015376678-A1 · Dec 31, 2015 · US
US9896714B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9896714-B2 |
| Application number | US-201013518785-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 17, 2010 |
| Priority date | Dec 23, 2009 |
| Publication date | Feb 20, 2018 |
| Grant date | Feb 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of detecting a phytase activity or a protease activity is described. The method comprises the steps of: (a) providing a composition comprising a phytate/protein complex in a liquid or a gel; wherein the phytate/protein complex provides a detectable property to the composition; (b) providing a sample that comprises or is suspected of comprising phytase activity and/or protease activity, wherein the phytase and/or protease activity is capable of causing a change in the detectable property of the composition; (c) contacting the composition with the sample; and (d) determining if there is a detectable change in detectable property of the composition.
Opening claim text (preview).
The invention claimed is: 1. A method of detecting a phytase activity or a protease activity comprising the steps of: providing a medium comprising a continuous phase and a disperse phase, wherein the disperse phase comprises: (1) a first component, the first component being a phytate or a phytic acid, and (2) a second component, the second component being a protein, wherein the first component and the second component are held together by one or more intermolecular interactions, wherein the phase provides a detectable property of turbidity to the medium; providing a sample that comprises one or more of the phytase activity or the protease activity, wherein the one or more of the phytase activity or the protease activity are capable of affecting the disperse phase to cause a change in the turbidity of the medium; contacting the medium with the sample; and determining that there is a detectable change in the turbidity of the medium to determine an amount of the phytase activity or the protease activity in the sample. 2. The method of claim 1 , wherein the protein in the disperse phase of the medium is selected from a group comprising caseins, soy proteins, rapeseed proteins, mustard proteins, porcine haemoglobins, N,N-dimethylated caseins, bovine beta-lactoglobulins, bovine serum albumins, swine serum albumins, lysozymes, or proteins modified with a chromophore. 3. The method of claim 1 , wherein the medium is between a pH of 1.8 and a pH of 8.5. 4. The method of claim 1 , wherein the method comprises comparing the change in the detectable property of the medium to a control. 5. The method of claim 1 , wherein the sample is a biological sample. 6. The method of claim 5 , wherein the biological sample is an enzyme preparation comprised of a fermentation broth, a feed or in an extract of the fermentation broth or the feed. 7. The method of claim 1 , wherein determining if there is a detectable change in the detectable property of the medium comprises one or more of a quantitative assay, a semi-quantitative assay or a qualitative assay. 8. A method of detecting a phytase activity comprising the steps of: providing a medium comprising a continuous phase and a disperse phase, wherein the disperse phase comprises: (1) a first component, the first component being a phytate or a phytic acid, and (2) a second component, the second component being a protein, wherein the first component and the second component are held together by one or more intermolecular interactions, wherein the disperse phase provides a detectable property of turbidity to the medium; providing a sample that comprises the phytase activity, wherein the phytase activity is capable of affecting the disperse phase to cause a change in the turbidity of the medium; contacting the medium with the sample, wherein one or more protease inhibitors are added to the sample in a sufficient amount as to inhibit any protease activity; and determining that there is a detectable change in the turbidity of the medium to determine an amount of the phytase activity in the sample. 9. The method of claim 8 , wherein the protein in the disperse phase of the medium is selected from a group comprising caseins, soy proteins, rapeseed proteins, mustard proteins, porcine haemoglobins, N,N-dimethylated caseins, bovine beta-lactoglobulins, bovine serum albumins, swine serum albumins, lysozymes, or proteins modified with a chromophore. 10. The method of claim 8 , wherein the sample is a biological sample. 11. The method of claim 10 , wherein the biological sample is an enzyme preparation comprised of a fermentation broth, a feed or in an extract of the fermentation broth or the feed. 12. The method of claim 8 , wherein determining if there is a detectable change in the detectable property of the medium comprises one or more of a quantitative assay, a semi-quantitative assay or a qualitative assay.
involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites · CPC title
Animal cells · CPC title
by separating the blood components (G01N15/05 takes precedence) · CPC title
involving nucleic acids · CPC title
involving phosphatase · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.